Supporting Equipment and Services
Shenzhen Lingfu Tuopu Biotechnology Co., Ltd. (referred to as Lingfu Tuopu) was established in 2015. It is an innovative CRO enterprise that focuses on animal research and provides services for preclinical research and evaluation. The company focuses on animal models and provides one-stop services for cell, pathology, protein, molecular, biochemical, behavioral, and other fields, empowering life science and biomedical research.
Founded in 2022, Shenzhen Termi Technology Co., Ltd. takes unique bioorthogonal (& click chemistry) and biochemical technology as the core and foundation, and relies on four major technology platforms of protein engineering, chemical synthesis, separation and purification, analysis and detection to support the development of underlying tools and raw materials for synthetic biology. The company is committed to providing life science reagents, consumables, instruments and CRO and CDMO services for enterprises and biotechnology innovators
Shenzhen Lingfu Top Biotechnology Co., Ltd. (hereinafter referred to as Lingfu Top) was established in 2015. It is an innovative CRO enterprise dedicated to animal research, serving preclinical research and evaluation. With animal models as its core, the company provides one-stop services in cell, pathology, protein, molecular, biochemical, and behavioral studies, empowering life science and biomedical research.
Shenzhen Saiqiao Biological Innovation Technology Co., Ltd. was established in March 2020, co-founded by Professor Zhang Youming, a PhD from the Department of Precision Instrumentation at Tsinghua University and a foreign academician of the Chinese Academy of Engineering. The core team has been responsible for major national biological instrument projects and possesses over 10 years of experience in instrument engineering and biotechnology. It is the earliest professional team in China to specialize in cell processing and automation equipment
Dapoo Biotech, incubated at the Hong Kong University of Science and Technology, was founded in 2018 and is committed to providing world-leading life science tools. It is a leading enterprise in high-throughput droplet microfluidic technology in China. The company has R&D and production centers in Shenzhen and Jiaxing, with a research team of nearly 100 people. It focuses on applying droplet microfluidic technology to the fields of biomedicine and precision medicine, and strives to become a complete solution provider integrating the research, development, and production of microfluidic chips, instruments, and reagents.
